CoreCap Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$853K Buy
62,291
+14,145
+29% +$218K 0.02% 417
2026
Q2
$767K Buy
48,146
+21,482
+81% +$330K 0.02% 444
2026
Q1
$377K Buy
26,664
+8,561
+47% +$126K 0.01% 585
2025
Q4
$256K Sell
18,103
-8,543
-32% -$124K 0.01% 708
2025
Q3
$394K Buy
26,646
+3,646
+16% +$54.5K 0.01% 582
2025
Q2
$348K Buy
23,000
+8,000
+53% +$117K 0.01% 583
2025
Q1
$216K Buy
15,000
+6,000
+67% +$91.7K 0.01% 658
2024
Q4
$136K Sell
9,000
-3,600
-29% -$57.9K 0.01% 822
2024
Q3
$207K Buy
12,600
+10,600
+530% +$174K 0.01% 679
2024
Q2
$32.8K Hold
2,000
– – ﹤0.01% 765
2024
Q1
$33.3K Buy
+2,000
New +$31K ﹤0.01% 1274
2022
Q4
$9.7K Buy
+700
New +$9.9K ﹤0.01% 1550

Other funds holding BCAT

CoreCap Advisors's BCAT Position: Q3 2026 in Review

CoreCap Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 29% in Q3 2026, buying an estimated $218K and bringing the position to 62,291 shares worth $853K. The position accounts for 0.02% of the portfolio, ranked #417.

CoreCap Advisors first reported a position in BCAT in Q4 2022 and has held it in 12 quarters since. 9 funds tracked by Wall St. Rank hold BCAT as of Q3 2026.

  • CoreCap Advisors held 62,291 shares of BlackRock Capital Allocation Term Trust worth $853K as of Q3 2026.
  • CoreCap Advisors bought 14,145 BlackRock Capital Allocation Term Trust shares in Q3 2026, an estimated $218K.
  • BlackRock Capital Allocation Term Trust made up 0.02% of CoreCap Advisors's portfolio in Q3 2026, its #417 holding.
  • CoreCap Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and has held it in 12 quarters since.
  • 9 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.